Patents Examined by B. J. Forman
  • Patent number: 6709816
    Abstract: A method for determining the genotype of one or more individuals at a polymorphic locus employs amplification of a region of DNA using primers containing tags and hybridization of the products to one or more probes on a solid support. The genotype or ratio of alleles is identified from the pattern of hybridization. The method can also be used to determine the frequency of different alleles in a population.
    Type: Grant
    Filed: October 18, 1999
    Date of Patent: March 23, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Xiaohua Huang, Thomas B Ryder, Paul Kaplan
  • Patent number: 6703203
    Abstract: This invention relates generally to the field of microarray technology. In particular, the invention provides an integrated microarray device, which device comprises a substrate comprising a plurality of distinct microlocations and a plurality of microarray chips, wherein the number of said microlocations equals to or is more than the number of said microarray chips. In preferred embodiments, the devices also comprises a temperature controller at some or all of the microlocations. The use of the integrated microarray devices for detecting interactions among various moieties in various fields, such as clinical diagnostics, drug discovery, environmental monitoring and forensic analysis, etc., are further provided.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: March 9, 2004
    Assignees: Capital Biochip Company, Ltd., Tsinghua University
    Inventors: Wei Shao, Junquan Xu, Wan-Li Xing, Jing Cheng
  • Patent number: 6699710
    Abstract: An array-based technology facilitates rapid correlated gene copy number and expression profiling of very large numbers of human tumors. Hundreds of cylindrical tissue biopsies (diameter 0.6 mm) from morphologically representative regions of individual tumors can be arrayed in a single paraffin block. Consecutive sections from such arrays provide targets for parallel in situ visualization and quantitation of DNA, RNA or protein targets. For example, amplifications of six loci (mybL2, erbB2, Cyclin-D1, myc, 17q23 and 20q13) were rapidly determined by fluorescence in situ hybridization from 372 ethanol-fixed breast cancers. Stratification of tumors by estrogen receptor and p53 expression data revealed distinct patterns of gene amplification in the various subgroups of breast cancer that may have prognostic utility. The tissue array technology is useful in the rapid molecular profiling of hundreds of normal and pathological tissue specimens or cultured cells.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: March 2, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Juha Kononen, Stephen B. Leighton, Olli-P. Kallioniemi
  • Patent number: 6686156
    Abstract: Methods for isothermal exponential amplification of a target polynucleotide are disclosed. The methods employ two transcription modules, the first module providing linear amplification resulting in RNA transcripts, and a second module providing for further (generally cyclical) amplification resulting in more RNA transcripts. In one aspect, the amplification of the first module is composite primer based. In a second aspect, the amplification of the first module is based on target switching to generate a primer extension product comprising a promoter sequence. In all aspects, the RNA transcripts of the first transcription module are subjected to further amplification by creating an intermediate product comprising a double stranded promoter region from which transcription can occur. The invention further provides compositions and kits for practicing said methods, as well as methods which use the amplification results.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: February 3, 2004
    Assignee: NuGen Technologies, Inc.
    Inventor: Nurith Kurn
  • Patent number: 6664044
    Abstract: In a PCR reaction, an extremely minute amount of a solution introduced by an ink-jet method is retained on a substrate for a long period of time without evaporation. On a substrate, a layer of liquid, that is hardly miscible with an extremely minute amount of a solution (minute droplet) intended to be retained, is formed. In the liquid layer, a minute droplet is held in contact with a surface of the substrate. If the minute droplet is aqueous, the liquid layer coated over the surface of the substrate may be oily.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: December 16, 2003
    Assignee: Toyota Jidosha Kabushiki Kaisha
    Inventor: Yoshihiro Sato
  • Patent number: 6649348
    Abstract: Apparatus and methods are disclosed for synthesizing a plurality of compounds on the surface of supports. Biopolymer features are attached to the surfaces of the supports. The synthesis generally comprises a plurality of steps. In the present invention at least two of the steps are performed by placing a support having a functionalized surface into a chamber of a flow cell and subjecting the surface to a step of the synthesis and placing the support into a chamber of another flow cell and subjecting the surface to another step of the synthesis. An apparatus generally comprises a plurality of flow cells and one or more fluid dispensing stations are mounted on the platform and are in fluid communication with one or more of the plurality of flow cells. A station for monomer addition to the surface of the support is mounted on the platform. The apparatus further comprises a mechanism for moving a support to and from the station for monomer addition and a flow cell and from one flow cell to another flow cell.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: November 18, 2003
    Assignee: Agilent Technologies Inc.
    Inventors: Jay K. Bass, John F. McEntee, Tim J. Lazaruk, Maryam Mobed-Miremadi
  • Patent number: 6649343
    Abstract: A DNA chip includes a large number of minute spots formed by dripping sample solutions onto a base plate. The base plate is provided with positional deviation-correcting means for displacing the spots and automatically correcting any positional deviation of each of the spots. The positional deviation-correcting means includes any one of at least one projection, at least one recess and electric field-generating means for providing charged states on the base plate centered at a correct position for each of the spots supplied on the base plate.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: November 18, 2003
    Assignee: NGK Insulators, Ltd.
    Inventors: Toshikazu Hirota, Takao Ohnishi, Yukihisa Takeuchi
  • Patent number: 6623924
    Abstract: The application provides genes causative of rheumatoid arthritis, which are located within ±1 centimorgan from DNA sequences to which the microsatellite markers D1S214, D1S253, D8S556, DXS1001, DXS1047, DXS1205, DXS1227 and/or DXS1232 are hybridized: a method for diagnosing rheumatoid arthritis, including amplifying the genomic DNA of a subject by PCR using at least one of the microsatellite markers as primer and comparing the PCR products thereof with the PCR products prepared in the same manner using the genomic DNA of a normal control; and a method for identifying the causative factors of rheumatoid arthritis including the same as described above.
    Type: Grant
    Filed: January 31, 2000
    Date of Patent: September 23, 2003
    Inventor: Shunichi Shiozawa
  • Patent number: 6605438
    Abstract: The disclosure relates to the stabilization of a fluid drop comprising a liquid solvent and solute, so that upon drying of the solvent, the solute is not preferentially concentrated at the edges of the residual spot, and more particularly relates to the preparation of microarrays containing biological reagents.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: August 12, 2003
    Inventor: Louis Dischler
  • Patent number: 6569620
    Abstract: The present invention includes a method and device for performing automated SELEX. The steps of the SELEX process are performed at one or more work stations on a work surface by a cartesian robotic manipulator controlled by a computer.
    Type: Grant
    Filed: January 19, 1999
    Date of Patent: May 27, 2003
    Assignee: SomaLogic, Inc.
    Inventors: Larry Gold, Dominic A. Zichi, Robert D. Jenison, Daniel J. Schneider
  • Patent number: 6562566
    Abstract: The present invention relates to a method of sequencing DNA by oligomer hybridization, DNA/RNA hybrid oligomers applied onto a support and optionally DNA oligomers and/or RNA oligomers being used as hybridization matrix.
    Type: Grant
    Filed: May 3, 2000
    Date of Patent: May 13, 2003
    Assignee: Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
    Inventor: Jörg Hoheisel
  • Patent number: 6548651
    Abstract: The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria. More specifically, the invention relates to peptide nucleic acid (PNA) sequences that are modified by conjugating cationic peptides to the PNA moiety in order to obtain novel PNA molecules that exhibit enhanced anti-infective properties.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: April 15, 2003
    Assignees: Pantheco A/S
    Inventors: Peter E. Nielsen, Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou, Margit Wissenbach, Birgit Kjaeldgaard Giwercman
  • Patent number: 6534266
    Abstract: An in situ hybridization method for detecting and specifically identifying transcription of a multiplicity of different target sequences in a cell is disclosed. The method includes assigning a different bar code to at least five target sequences, with each target sequence containing at least one predetermined subsequence. Each bar code contains at least one fluorochrome, and at least one bar code comprises at least two different, spectrally distinguishable fluorochromes. A probe set specific for each target sequence is provided in the method. Each probe set contains a hybridization probe complementary to each subsequence in the target sequence. Each probe is labeled with a fluorochrome, and the fluorochromes in each probe set collectively correspond to the bar code for the target sequence of that probe set.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: March 18, 2003
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventor: Robert H. Singer
  • Patent number: 6521405
    Abstract: The invention relates to improvements in cell-free systems for initiating DNA replication under cell cycle control. The system comprises a synchronous population of G1 nuclei which have been released from G0; and S phase cytosol. In a preferred aspect, a polypeptide is supplied to the system, wherein the polypeptide is Cdc6 and/or at least one MCM protein. The system is suitable for DNA replication assays, for example to test substances which modulate DNA replication.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: February 18, 2003
    Assignee: Cancer Research Campaign Technology Limited
    Inventors: Ronald Laskey, Gareth Haydn Williams, Torsten Krude, Kal Stoeber, Anthony David Mills
  • Patent number: 6518018
    Abstract: Described herein are methods and reagents for the selection of protein molecules that make use of RNA-protein fusions.
    Type: Grant
    Filed: January 28, 1999
    Date of Patent: February 11, 2003
    Assignee: The General Hospital Corporation
    Inventors: Jack W. Szostak, Richard W. Roberts
  • Patent number: 6503715
    Abstract: A Nucleic acid ligand “Biochip” is disclosed, consisting of a solid support to which one or more specific Nucleic acid ligands is attached in a spatially defined manner. Each Nucleic acid ligand binds specifically and avidly to a particular Target molecule contained within a Test mixture, such as a Bodily fluid. The Target molecules include, but are not limited to, proteins (cellular, viral, bacterial, etc.) hormones, sugars, metabolic byproducts, cofactor, and intermediates, drugs, and toxins. Contacting the Test mixture with the Biochip leads to the binding of a Target molecule to its cognate Nucleic acid ligand. Binding of Target to the Nucleic acid ligand results in a detectable change at each specific location on the Biochip. The detectable change can include, but is not limited to, a change in fluorescence, or a change in a physical parameter, such as electrical conductance or refractive index, at each location on the Biochip.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: January 7, 2003
    Assignee: SomaLogic, Inc.
    Inventors: Larry Gold, Dan Drolet, Dom Zichi, Sumedha Jayasena, Steve Creighton, Stanley Gill
  • Patent number: 6492118
    Abstract: A method is provided for immobilizing a ligand, e.g., a nucleic acid, on a solid support. The method includes providing a solid support containing an immobilized latent thiol group, activating the thiol group, contacting the activated thiol group with a nucleic acid comprising an acrylamide functional group, and forming a covalent bond between the two groups, thereby immobilizing the nucleic acid to the solid support. Kits containing the solid supports and method of utilizing the solid supports are also provided.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: December 10, 2002
    Assignee: Matrix Technologies Corporation
    Inventors: Ezra S. Abrams, Tianhong Zhang, Slawomir Mielewczyk, Brian C. Patterson
  • Patent number: 6489111
    Abstract: A purpose of the present invention is to provide a gene amplification apparatus with simple operation, wherein the apparatus can heat and cool gene rapidly and a thermal cycle can be operated in a relatively short period and a method thereof, a method for preparing immobilized DNA library suitable to the above apparatus and a method for comparing genes systematically. The apparatus for preparing immobilized DNA library according to the present invention comprises a reaction body 10 on which a grooved portion for receiving a container is formed, a cap portion 50 provided at an upper portion of the reaction body and a container 12 formed by substrates for immobilizing DNA, wherein the cap portion 50 including means for heating/cooling 51 and means for cooling 52.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: December 3, 2002
    Assignee: Toyo Kohan Co., Ltd.
    Inventors: Kojiro Takahashi, Michifumi Tanga
  • Patent number: 6468743
    Abstract: A method or detecting the presence of living or dead microorganisms and viruses in a sample comprises adding to a pre-determined volume of a sample comprising nucleic acid-containing microbe (s) and/or virus (es), known amounts of a pair of primers binding to sequences up-stream and down-stream to a universal or specific microbial and/or viral nucleic acid sequence and polymerase chain reaction (PCR) reagents, cycling the mixture to amplify the universal or specific microbial and/or viral nucleic acid sequence; adding a polynucleotide comprising a DNA internal segment that is hybridizably complementary to at least a portion of the universal or specific nucleic acid sequence; and a first and a second DNA arm segment adjoining the DNA internal segment, the first DNA arm segment ending in a 5′ terminus and the second DNA arm segment ending in a 3′ terminus, the arms segments comprising nucleotide sequences such that they are hybridizably complementary to one another.
    Type: Grant
    Filed: May 17, 1999
    Date of Patent: October 22, 2002
    Assignee: ConAgra Grocery Products Company
    Inventors: Thomas L. Romick, Mark S. Fraser
  • Patent number: 6465178
    Abstract: Method and reagent composition for covalent attachment of target molecules, such as nucleic acids, onto the surface of a substrate. The reagent composition includes groups capable of covalently binding to the target molecule. Optionally, the composition can contain photoreactive groups for use in attaching the reagent composition to the surface. The reagent composition can be used to provide activated slides for use in preparing microarrays of nucleic acids.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: October 15, 2002
    Assignee: Surmodics, Inc.
    Inventors: Ralph A. Chappa, Sheau-Ping Hu, Dale G. Swan, Melvin J. Swanson, Patrick E. Guire